Incremental Prognostic Value of Quantified Vulnerable Plaque by Cardiac Computed Tomography: A Pilot Study. Issue 6 (November 2016)

• Record Type: Journal Article
• Authors: Dwivedi, Girish; Liu, Yingwei; Tewari, Shrankhala; Inacio, Joao; Pelletier-Galarneau, Matthieu; Chow, Benjamin J.W.
• Is Part Of: Journal of thoracic imaging. Volume 31:Issue 6(2016)
• Publication Date: 2016-11
• Subjects: prognostic value -- quantified vulnerable plaque -- cardiac computed tomography -- atherosclerosis; Chest -- Radiography -- Periodicals; Chest -- Diseases -- Diagnosis -- Periodicals; 617.540757
• DOI: 10.1097/RTI.0000000000000236
• Languages: English
• ISSNs: 0883-5993

Abstract

Abstract : Background: Coronary computed tomography (CT) angiography (CCTA) has the ability to detect, characterize, and quantify atherosclerotic plaques. The aim of our study was to evaluate the prognostic power of CCTA-quantified plaque subtypes. Materials and Methods: A total of 36 patients with adverse events and 36 Morise score–matched patients who remained event free on follow-up were identified. Using CCTA images, plaque subtype volumes in the major epicardial arteries were analyzed using predetermined attenuation ranges in Hounsfield units (HU): 1 to 30 HU (low attenuating), 31 to 70 HU (intermediate attenuating), 71 to 150 HU (high attenuating), and mean coronary lumen+2 SD to 1000 HU (calcified). Each epicardial artery was divided into proximal, mid, and distal segments, and plaque volumes were normalized for arterial segment length. Results: The baseline characteristics of the 2 cohorts were similar. Low-attenuation and intermediate-attenuation plaque volumes were greater in the proximal segments as well as in the entire length in the adverse event compared with the event-free group. High-attenuation plaque volume was increased only in the proximal segments in the adverse event group. There was no difference in the volume of calcified plaque between the 2 groups. The log rank test using a cutoff of 3.99 mm 3 /mm for combined intermediate and low plaque volume showed more adverse events in patients with a plaque volume of ≥3.99 mm 3 /mm. Conclusions: Adverse events appear to be associated with greater volumes of low-attenuation and intermediate-attenuation plaques that reflect lipid and fibrous atherosclerosis. The difference between the 2 groups is most apparent in the proximal epicardial arteries.